These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15870705)

  • 1. A germ line mutation that delays prostate cancer progression and prolongs survival in a murine prostate cancer model.
    Majeed N; Blouin MJ; Kaplan-Lefko PJ; Barry-Shaw J; Greenberg NM; Gaudreau P; Bismar TA; Pollak M
    Oncogene; 2005 Jul; 24(29):4736-40. PubMed ID: 15870705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced growth of human breast cancer xenografts in hosts homozygous for the lit mutation.
    Yang XF; Beamer WG; Huynh H; Pollak M
    Cancer Res; 1996 Apr; 56(7):1509-11. PubMed ID: 8603394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of the direct effects of metabolic factors on somatotrope function in a non-human primate model, Papio anubis.
    Luque RM; Gahete MD; Valentine RJ; Kineman RD
    J Mol Endocrinol; 2006 Aug; 37(1):25-38. PubMed ID: 16901921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential responses of the growth hormone axis in two rat models of streptozotocin-induced insulinopenic diabetes.
    Kim E; Sohn S; Lee M; Jung J; Kineman RD; Park S
    J Endocrinol; 2006 Feb; 188(2):263-70. PubMed ID: 16461552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced growth of human sarcoma xenografts in hosts homozygous for the lit mutation.
    Deitel K; Dantzer D; Ferguson P; Pollak M; Beamer W; Andrulis I; Bell R
    J Surg Oncol; 2002 Oct; 81(2):75-9. PubMed ID: 12355407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of leptin replacement on hypothalamic-pituitary growth hormone axis function and circulating ghrelin levels in ob/ob mice.
    Luque RM; Huang ZH; Shah B; Mazzone T; Kineman RD
    Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E891-9. PubMed ID: 17122091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human prostate cancer xenografts in lit/lit mice exhibit reduced growth and androgen-independent progression.
    Takahara K; Tearle H; Ghaffari M; Gleave ME; Pollak M; Cox ME
    Prostate; 2011 Apr; 71(5):525-37. PubMed ID: 20878948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138.
    Heinrich E; Schally AV; Buchholz S; Rick FG; Halmos G; Mile M; Groot K; Hohla F; Zarandi M; Varga JL
    Prostate; 2008 Dec; 68(16):1763-72. PubMed ID: 18729085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variation in the SST gene and its receptors in relation to circulating levels of insulin-like growth factor-I, IGFBP3, and prostate cancer risk.
    Johansson M; McKay JD; Wiklund F; Rinaldi S; Hallmans G; Bälter K; Adami HO; Grönberg H; Stattin P; Kaaks R
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1644-50. PubMed ID: 19423539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of insulin-like growth factor-I for prostate cancer therapies.
    Kojima S; Inahara M; Suzuki H; Ichikawa T; Furuya Y
    Int J Urol; 2009 Feb; 16(2):161-7. PubMed ID: 19183230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer.
    Schally AV; Varga JL; Engel JB
    Nat Clin Pract Endocrinol Metab; 2008 Jan; 4(1):33-43. PubMed ID: 18084344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a high-glucose environment on the pituitary growth hormone-releasing hormone receptor: type 1 diabetes compared with in vitro glucotoxicity.
    Bédard K; Strecko J; Thériault K; Bédard J; Veyrat-Durebex C; Gaudreau P
    Am J Physiol Endocrinol Metab; 2008 Apr; 294(4):E740-51. PubMed ID: 18285528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factors and their binding proteins in prostate cancer: cause or consequence?
    Meinbach DS; Lokeshwar BL
    Urol Oncol; 2006; 24(4):294-306. PubMed ID: 16818181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naturally-occurring missense mutations in the human growth hormone-releasing hormone receptor alter ligand binding.
    Alba M; Salvatori R
    J Endocrinol; 2005 Sep; 186(3):515-21. PubMed ID: 16135671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.
    Canzian F; McKay JD; Cleveland RJ; Dossus L; Biessy C; Boillot C; Rinaldi S; Llewellyn M; Chajès V; Clavel-Chapelon F; Téhard B; Chang-Claude J; Linseisen J; Lahmann PH; Pischon T; Trichopoulos D; Trichopoulou A; Zilis D; Palli D; Tumino R; Vineis P; Berrino F; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Pera G; Barricarte A; Chirlaque MD; Quirós JR; Larrañaga N; Martínez-García C; Allen NE; Key TJ; Bingham SA; Khaw KT; Slimani N; Norat T; Riboli E; Kaaks R
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2316-25. PubMed ID: 16214911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated growth hormone deficiency: testing the little mouse hypothesis in man and exclusion of mutations within the extracellular domain of the growth hormone-releasing hormone receptor.
    Cao Y; Wagner JK; Hindmarsh PC; Eblé A; Mullis PE
    Pediatr Res; 1995 Dec; 38(6):962-6. PubMed ID: 8618801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model.
    Raina K; Blouin MJ; Singh RP; Majeed N; Deep G; Varghese L; Glodé LM; Greenberg NM; Hwang D; Cohen P; Pollak MN; Agarwal R
    Cancer Res; 2007 Nov; 67(22):11083-91. PubMed ID: 18006855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of 5'-promoter activity of the rat growth hormone and growth hormone-releasing hormone receptor genes in the MtT/S and MtT/E cells.
    Nogami H; Hiraoka Y; Inoue K; Aiso S; Hisano S
    Neuroendocrinology; 2006; 84(1):31-41. PubMed ID: 17090972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. beta1A integrin expression is required for type 1 insulin-like growth factor receptor mitogenic and transforming activities and localization to focal contacts.
    Goel HL; Breen M; Zhang J; Das I; Aznavoorian-Cheshire S; Greenberg NM; Elgavish A; Languino LR
    Cancer Res; 2005 Aug; 65(15):6692-700. PubMed ID: 16061650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep in spontaneous dwarf rats.
    Peterfi Z; Obal F; Taishi P; Gardi J; Kacsoh B; Unterman T; Krueger JM
    Brain Res; 2006 Sep; 1108(1):133-46. PubMed ID: 16859658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.